Memphis, TN, United States of America

Charles B Duke

This inventor holds 13 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents, primarily in Cancer Therapeutics. Top assignees: The University of Tennessee Research Foundation, Gtx Corporation, Oncternal Therapeutics, Inc.. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles B Duke. Retrieved from https://idiyas.com/inventor/charles-b-duke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 76.9

 

 

Average Co-Inventor Count = 8.6

ph-index = 8

Forward Citations = 123(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Selective Androgen Receptor Degrader
SARD Ligands
Cancer Treatment
Pharmaceutical Compounds
Drug Development
Therapeutic Applications
Oncology
Ligand Design
Biological Activity
Targeted Therapy
13 patents (USPTO):Explore Patents

Title: The Innovations of Charles B Duke

Introduction

Charles B Duke is a prominent inventor based in Memphis, TN, known for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, Duke has made remarkable strides in developing treatments for various medical conditions, particularly those related to androgen receptors.

Latest Patents

Duke's latest patents include innovative compounds known as selective androgen receptor degraders (SARDs). These compounds, which encompass novel indole, indazole, benzimidazole, benzotriazole, indoline, quinolone, isoquinoline, and carbazole structures, are designed to treat hyperproliferations of the prostate, including pre-malignancies, benign prostatic hyperplasia, and prostate cancer. Additionally, he has developed 3-amino propanamide SARD compounds that target similar conditions, including advanced prostate cancer and androgenic alopecia. His inventions aim to reduce the levels and activity of androgen receptors, addressing various diseases such as Kennedy's disease, amyotrophic lateral sclerosis (ALS), and uterine fibroids.

Career Highlights

Throughout his career, Charles B Duke has worked with esteemed organizations, including the University of Tennessee Research Foundation and GTx Corporation. His work has significantly impacted the pharmaceutical industry, particularly in the development of targeted therapies for cancer and other androgen-related conditions.

Collaborations

Duke has collaborated with notable professionals in his field, including James T Dalton and Duane Douglas Miller. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Charles B Duke's innovative work in the realm of selective androgen receptor degraders showcases his dedication to improving medical treatments for serious health conditions. His contributions continue to influence the pharmaceutical landscape, making him a noteworthy figure in the field of invention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…